In an article published in 2013, researchers explored the impact of autoimmune diseases (particularly rheumatoid arthritis, psoriasis, and systemic sclerosis) and anti-TNF-α therapy on the clinical and immunological periodontal parameters of diseased subjects and systemically healthy controls [54]. This evidence concerns the gene TNF and psoriasis.